BlueRock Therapeutics
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease (NCT06944522) | BlueRock Therapeutics | 2025-06-17 |
| A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO) (NCT06789445) | BlueRock Therapeutics | 2025-03-10 |
| Noninterventional Study Evaluating Parkinson's Disease Diary Use (NCT05363046) | BlueRock Therapeutics | 2022-07-29 |
| Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease (NCT04802733) | BlueRock Therapeutics | 2021-05-03 |
Track BlueRock Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.